Jamie Dananberg

Jamie Dananberg

Chief Tech/Sci/R&D Officer at ANNEXON, INC.

Net worth: 669 814 $ as of 31/05/2026

68 year
Health Technology
Consumer Services

Profile

Jamie Dananberg is currently Chief Medical Officer & Executive Vice President at Annexon, Inc. since 2023 and serves as a Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include VP-Translational Medicine & Tailored Therapeutics at Eli Lilly & Co. from 2000 to 2012, Executive Vice President at Takeda Pharmaceutical Co., Ltd. from 2012 to 2015, and Chief Medical Officer at Unity Biotechnology, Inc. from 2016 to 2023.
Education includes undergraduate and doctorate degrees from Tufts University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/03/2026 123,582 ( 0.08% ) 669 814 $ 31/05/2026

Jamie Dananberg active positions

CompaniesPositionStart
ANNEXON, INC. Chief Tech/Sci/R&D Officer 27/07/2023
Director/Board Member -

Former positions of Jamie Dananberg

CompaniesPositionEnd
UNITY BIOTECHNOLOGY, INC. Chief Tech/Sci/R&D Officer 30/04/2023
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/10/2015
ELI LILLY AND COMPANY Corporate Officer/Principal 01/09/2012
See the detail of Jamie Dananberg's experience

Training of Jamie Dananberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Jamie Dananberg